NewsAmgen upgraded to "outperform"
24.10.07 - Credit Suisse
NEW YORK, October 24 (newratings.com) - Analysts at Credit Suisse upgrade Amgen Inc (AMGN) from "neutral" to "outperform." The target price has been raised from $56 to $65.
Share Empfehlen Sie diesen Artikel einem Freund!
AMGN zu meinen Aktien hinzufügen und E-Mail Alerts auf Amgen abonnieren